New heart valve fix could help High-Risk patients avoid major surgery
NCT ID NCT06700239
Summary
This study is testing a new device called the MIA-T system, which is designed to repair a leaky tricuspid heart valve without open-heart surgery. It will involve 600 patients who have severe valve leakage causing symptoms like shortness of breath, and who are considered too high-risk for traditional surgery. The goal is to see if this less invasive procedure is safe and can help patients live longer, avoid hospital stays for heart failure, and prevent the need for future valve surgeries.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.